I-015

Itraconazole solution

2.0 mg/mL (Methanol with 1% 1M HCl), ampule of 1 mL, certified reference material, Cerilliant^®

• Empirische Formel (Hill-System): C₃₅H₃₈Cl₂N₈O₄
• CAS-Nummer: 84625-61-6
• Molekulargewicht: 705.63
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: certified reference material
• Qualitätsniveau: 300
• Form: liquid
• Leistungsmerkmale: (Snap-N-Spike^®)
• Verpackung: ampule of 1 mL
• Hersteller/Markenname: Cerilliant^®
• Konzentration: 2.0 mg/mL (Methanol with 1% 1M HCl)
• Methode(n): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Anwendung(en): clinical testing
• Format: single component solution
• Lagertemp.: −20°C
• InChI: 1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1
• InChIKey: VHVPQPYKVGDNFY-ZPGVKDDISA-N

Beschreibung

Allgemeine Beschreibung

Itraconazole is an antifungal drug prescribed for oral or intravenous treatment of fungal infections. The drug is sold under trade names such as Sporanoxor Onmel^®. This Certified Spiking Solution^® is suitable as starting material for calibrators, controls, or linearity standards for clinical and diagnostic testing or therapeutic drug monitoring of itraconazole in patient blood, serum, or plasma samples by LC-MS/MS or HPLC.

Anwendung

• Enhanced drug delivery: A study by Soe HMSH et al. discusses a synthetic citric crosslinked beta-cyclodextrin derivative designed to improve the solubility, cytotoxicity, and antifungal activity of drugs like Itraconazole. This innovative approach enhances the bioavailability and therapeutic efficacy of antifungal medications, crucial for treating persistent fungal infections (Soe HMSH et al., 2023).


• Novel formulation techniques: Research by Becelaere J et al. explores solvent electrospinning to create amorphous solid dispersions with high Itraconazole content. This method significantly enhances drug loading and release potential, providing new insights into pharmaceutical formulation and controlled drug delivery systems (Becelaere J et al., 2023).


• Pharmaceutical sciences research: A study by Nunes PD et al. uses in vitro tools to predict the bioavailability of amorphous solid dispersions of drugs like Itraconazole. Their work provides crucial mechanistic insights into drug dissolution and permeation, aiding in the optimization of oral dosage forms for enhanced therapeutic effectiveness (Nunes PD et al., 2023).


• Optimization of sustained release formulations: Research by Wang W et al. on optimizing the O/W emulsion solvent evaporation method for Itraconazole microspheres highlights advancements in sustained-release formulations. This approach aims to improve dosing regimens and patient compliance in chronic treatments (Wang W et al., 2023).

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation

Onmel is a registered trademark of Merz Pharmaceuticals, LLC

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Piktogramme: GHS02,GHS06,GHS08,GHS05
• Signalwort: Danger
• H-Sätze: H225,H290,H301 + H311 + H331,H370
• P-Sätze: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - Met. Corr. 1 - STOT SE 1
• Zielorgane: Eyes,Central nervous system
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 49.5 °F - closed cup
• Flammpunkt (°C): 9.7 °C - closed cup